Close Menu
ROTTERDAM (GenomeWeb) – Whole-genome sequencing of tumor biopsies has helped more than 200 advanced cancer patients in the Netherlands obtain off-label treatment with an anti-cancer drug so far, providing a clinical benefit for about a third of them, according to a presentation at the Association for Molecular Pathology's AMP Europe 2018 meeting here yesterday.
Paul Roepman, a clinical molecular biologist at the Hartwig Medical Foundation in Amsterdam, presented the results as part of an update on a Dutch national initiative, under which the foundation provides whole

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.